Industry Research Reports

Home > Reports > New Technology > COVID-19 Molecular Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

COVID-19 Molecular Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: New Technology

Published: 2024-01-14

Pages: 152 Pages

Report ld: 2632145

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.

The global market for COVID-19 Molecular Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for COVID-19 Molecular Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of COVID-19 Molecular Diagnostics by region & country, by Type, and by Application.

The COVID-19 Molecular Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Molecular Diagnostics.

Market Segmentation

Report Metric
Details
Report Title
COVID-19 Molecular Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global COVID-19 Molecular Diagnostics Companies Covered
Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Thermo Fisher, Bio-rad, Agilent, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, QIAGEN, Bioer, Biosynex, Esco, Analytik Jena, Techne, Da An Gene, BGI, Shanghai ZJ Bio-Tech
Global COVID-19 Molecular Diagnostics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global COVID-19 Molecular Diagnostics Market, Segment by Type
High-throughput Sequencing

Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR

Immunological Detection
Global COVID-19 Molecular Diagnostics Market, Segment by Application
Hospitals

Scientific Research

Biodiagnostics
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of COVID-19 Molecular Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of COVID-19 Molecular Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of COVID-19 Molecular Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 COVID-19 Molecular Diagnostics Product Introduction
    1.2 Global COVID-19 Molecular Diagnostics Market Size Forecast
    1.3 COVID-19 Molecular Diagnostics Market Trends & Drivers
        1.3.1 COVID-19 Molecular Diagnostics Industry Trends
        1.3.2 COVID-19 Molecular Diagnostics Market Drivers & Opportunity
        1.3.3 COVID-19 Molecular Diagnostics Market Challenges
        1.3.4 COVID-19 Molecular Diagnostics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global COVID-19 Molecular Diagnostics Players Revenue Ranking (2023)
    2.2 Global COVID-19 Molecular Diagnostics Revenue by Company (2019-2024)
    2.3 Key Companies COVID-19 Molecular Diagnostics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies COVID-19 Molecular Diagnostics Product Offered
    2.5 Key Companies Time to Begin Mass Production of COVID-19 Molecular Diagnostics
    2.6 COVID-19 Molecular Diagnostics Market Competitive Analysis
        2.6.1 COVID-19 Molecular Diagnostics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by COVID-19 Molecular Diagnostics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 High-throughput Sequencing
        3.1.2 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
        3.1.3 Immunological Detection
    3.2 Global COVID-19 Molecular Diagnostics Sales Value by Type
        3.2.1 Global COVID-19 Molecular Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global COVID-19 Molecular Diagnostics Sales Value, by Type (2019-2030)
        3.2.3 Global COVID-19 Molecular Diagnostics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Scientific Research
        4.1.3 Biodiagnostics
    4.2 Global COVID-19 Molecular Diagnostics Sales Value by Application
        4.2.1 Global COVID-19 Molecular Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global COVID-19 Molecular Diagnostics Sales Value, by Application (2019-2030)
        4.2.3 Global COVID-19 Molecular Diagnostics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global COVID-19 Molecular Diagnostics Sales Value by Region
        5.1.1 Global COVID-19 Molecular Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global COVID-19 Molecular Diagnostics Sales Value by Region (2019-2024)
        5.1.3 Global COVID-19 Molecular Diagnostics Sales Value by Region (2025-2030)
        5.1.4 Global COVID-19 Molecular Diagnostics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        5.2.2 North America COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        5.3.2 Europe COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        5.4.2 Asia Pacific COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        5.5.2 South America COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        5.6.2 Middle East & Africa COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value
    6.3 United States
        6.3.1 United States COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        6.3.2 United States COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States COVID-19 Molecular Diagnostics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        6.4.2 Europe COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe COVID-19 Molecular Diagnostics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        6.5.2 China COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China COVID-19 Molecular Diagnostics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        6.6.2 Japan COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan COVID-19 Molecular Diagnostics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        6.7.2 South Korea COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea COVID-19 Molecular Diagnostics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        6.8.2 Southeast Asia COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia COVID-19 Molecular Diagnostics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India COVID-19 Molecular Diagnostics Sales Value, 2019-2030
        6.9.2 India COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India COVID-19 Molecular Diagnostics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Cellex
        7.1.1 Cellex Profile
        7.1.2 Cellex Main Business
        7.1.3 Cellex COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.1.4 Cellex COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.1.5 Cellex Recent Developments
    7.2 Abbott
        7.2.1 Abbott Profile
        7.2.2 Abbott Main Business
        7.2.3 Abbott COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.2.4 Abbott COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.2.5 Abbott Recent Developments
    7.3 Roche
        7.3.1 Roche Profile
        7.3.2 Roche Main Business
        7.3.3 Roche COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.3.4 Roche COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.3.5 BioMedomics Recent Developments
    7.4 BioMedomics
        7.4.1 BioMedomics Profile
        7.4.2 BioMedomics Main Business
        7.4.3 BioMedomics COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.4.4 BioMedomics COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.4.5 BioMedomics Recent Developments
    7.5 BD
        7.5.1 BD Profile
        7.5.2 BD Main Business
        7.5.3 BD COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.5.4 BD COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.5.5 BD Recent Developments
    7.6 Henry Schein
        7.6.1 Henry Schein Profile
        7.6.2 Henry Schein Main Business
        7.6.3 Henry Schein COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.6.4 Henry Schein COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.6.5 Henry Schein Recent Developments
    7.7 Safecare Bio-Tech
        7.7.1 Safecare Bio-Tech Profile
        7.7.2 Safecare Bio-Tech Main Business
        7.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.7.4 Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.7.5 Safecare Bio-Tech Recent Developments
    7.8 Thermo Fisher
        7.8.1 Thermo Fisher Profile
        7.8.2 Thermo Fisher Main Business
        7.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.8.4 Thermo Fisher COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.8.5 Thermo Fisher Recent Developments
    7.9 Bio-rad
        7.9.1 Bio-rad Profile
        7.9.2 Bio-rad Main Business
        7.9.3 Bio-rad COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.9.4 Bio-rad COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.9.5 Bio-rad Recent Developments
    7.10 Agilent
        7.10.1 Agilent Profile
        7.10.2 Agilent Main Business
        7.10.3 Agilent COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.10.4 Agilent COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.10.5 Agilent Recent Developments
    7.11 Ortho Clinical Diagnostics
        7.11.1 Ortho Clinical Diagnostics Profile
        7.11.2 Ortho Clinical Diagnostics Main Business
        7.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.11.4 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.11.5 Ortho Clinical Diagnostics Recent Developments
    7.12 Zhejiang Orient Gene Biotech
        7.12.1 Zhejiang Orient Gene Biotech Profile
        7.12.2 Zhejiang Orient Gene Biotech Main Business
        7.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.12.4 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.12.5 Zhejiang Orient Gene Biotech Recent Developments
    7.13 Innovita Biological Technology
        7.13.1 Innovita Biological Technology Profile
        7.13.2 Innovita Biological Technology Main Business
        7.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.13.4 Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.13.5 Innovita Biological Technology Recent Developments
    7.14 Guangzhou Wondfo Biotech
        7.14.1 Guangzhou Wondfo Biotech Profile
        7.14.2 Guangzhou Wondfo Biotech Main Business
        7.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.14.4 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.14.5 Guangzhou Wondfo Biotech Recent Developments
    7.15 Guangdong Hecin-Scientific
        7.15.1 Guangdong Hecin-Scientific Profile
        7.15.2 Guangdong Hecin-Scientific Main Business
        7.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.15.4 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.15.5 Guangdong Hecin-Scientific Recent Developments
    7.16 Dynamiker Biotechnology (Tianjin)
        7.16.1 Dynamiker Biotechnology (Tianjin) Profile
        7.16.2 Dynamiker Biotechnology (Tianjin) Main Business
        7.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
    7.17 ADVAITE
        7.17.1 ADVAITE Profile
        7.17.2 ADVAITE Main Business
        7.17.3 ADVAITE COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.17.4 ADVAITE COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.17.5 ADVAITE Recent Developments
    7.18 Mayo Clinic Laboratories
        7.18.1 Mayo Clinic Laboratories Profile
        7.18.2 Mayo Clinic Laboratories Main Business
        7.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.18.4 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.18.5 Mayo Clinic Laboratories Recent Developments
    7.19 Chembio Diagnostics
        7.19.1 Chembio Diagnostics Profile
        7.19.2 Chembio Diagnostics Main Business
        7.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.19.4 Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.19.5 Chembio Diagnostics Recent Developments
    7.20 Mount Sinai Laboratory
        7.20.1 Mount Sinai Laboratory Profile
        7.20.2 Mount Sinai Laboratory Main Business
        7.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.20.4 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.20.5 Mount Sinai Laboratory Recent Developments
    7.21 QIAGEN
        7.21.1 QIAGEN Profile
        7.21.2 QIAGEN Main Business
        7.21.3 QIAGEN COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.21.4 QIAGEN COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.21.5 QIAGEN Recent Developments
    7.22 Bioer
        7.22.1 Bioer Profile
        7.22.2 Bioer Main Business
        7.22.3 Bioer COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.22.4 Bioer COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.22.5 Bioer Recent Developments
    7.23 Biosynex
        7.23.1 Biosynex Profile
        7.23.2 Biosynex Main Business
        7.23.3 Biosynex COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.23.4 Biosynex COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.23.5 Biosynex Recent Developments
    7.24 Esco
        7.24.1 Esco Profile
        7.24.2 Esco Main Business
        7.24.3 Esco COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.24.4 Esco COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.24.5 Esco Recent Developments
    7.25 Analytik Jena
        7.25.1 Analytik Jena Profile
        7.25.2 Analytik Jena Main Business
        7.25.3 Analytik Jena COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.25.4 Analytik Jena COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.25.5 Analytik Jena Recent Developments
    7.26 Techne
        7.26.1 Techne Profile
        7.26.2 Techne Main Business
        7.26.3 Techne COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.26.4 Techne COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.26.5 Techne Recent Developments
    7.27 Da An Gene
        7.27.1 Da An Gene Profile
        7.27.2 Da An Gene  Main Business
        7.27.3 Da An Gene COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.27.4 Da An Gene COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.27.5 Da An Gene Recent Developments
    7.28 BGI
        7.28.1 BGI Profile
        7.28.2 BGI  Main Business
        7.28.3 BGI COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.28.4 BGI COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.28.5 BGI Recent Developments
    7.29 Shanghai ZJ Bio-Tech
        7.29.1 Shanghai ZJ Bio-Tech Profile
        7.29.2 Shanghai ZJ Bio-Tech  Main Business
        7.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions
        7.29.4 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue (US$ Million) & (2019-2024)
        7.29.5 Shanghai ZJ Bio-Tech Recent Developments

 8 Industry Chain Analysis
    8.1 COVID-19 Molecular Diagnostics Industrial Chain
    8.2 COVID-19 Molecular Diagnostics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 COVID-19 Molecular Diagnostics Sales Model
        8.5.2 Sales Channel
        8.5.3 COVID-19 Molecular Diagnostics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. COVID-19 Molecular Diagnostics Market Trends
    Table 2. COVID-19 Molecular Diagnostics Market Drivers & Opportunity
    Table 3. COVID-19 Molecular Diagnostics Market Challenges
    Table 4. COVID-19 Molecular Diagnostics Market Restraints
    Table 5. Global COVID-19 Molecular Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global COVID-19 Molecular Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies COVID-19 Molecular Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies COVID-19 Molecular Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of COVID-19 Molecular Diagnostics
    Table 10. Global COVID-19 Molecular Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global COVID-19 Molecular Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global COVID-19 Molecular Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global COVID-19 Molecular Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global COVID-19 Molecular Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global COVID-19 Molecular Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global COVID-19 Molecular Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global COVID-19 Molecular Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global COVID-19 Molecular Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global COVID-19 Molecular Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global COVID-19 Molecular Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global COVID-19 Molecular Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global COVID-19 Molecular Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Cellex Basic Information List
    Table 32. Cellex Description and Business Overview
    Table 33. Cellex COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Cellex (2019-2024)
    Table 35. Cellex Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. BioMedomics Basic Information List
    Table 47. BioMedomics Description and Business Overview
    Table 48. BioMedomics COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BioMedomics (2019-2024)
    Table 50. BioMedomics Recent Developments
    Table 51. BD Basic Information List
    Table 52. BD Description and Business Overview
    Table 53. BD COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BD (2019-2024)
    Table 55. BD Recent Developments
    Table 56. Henry Schein Basic Information List
    Table 57. Henry Schein Description and Business Overview
    Table 58. Henry Schein COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Henry Schein (2019-2024)
    Table 60. Henry Schein Recent Developments
    Table 61. Safecare Bio-Tech Basic Information List
    Table 62. Safecare Bio-Tech Description and Business Overview
    Table 63. Safecare Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Safecare Bio-Tech (2019-2024)
    Table 65. Safecare Bio-Tech Recent Developments
    Table 66. Thermo Fisher Basic Information List
    Table 67. Thermo Fisher Description and Business Overview
    Table 68. Thermo Fisher COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Thermo Fisher (2019-2024)
    Table 70. Thermo Fisher Recent Developments
    Table 71. Bio-rad Basic Information List
    Table 72. Bio-rad Description and Business Overview
    Table 73. Bio-rad COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Bio-rad (2019-2024)
    Table 75. Bio-rad Recent Developments
    Table 76. Agilent Basic Information List
    Table 77. Agilent Description and Business Overview
    Table 78. Agilent COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Agilent (2019-2024)
    Table 80. Agilent Recent Developments
    Table 81. Ortho Clinical Diagnostics Basic Information List
    Table 82. Ortho Clinical Diagnostics Description and Business Overview
    Table 83. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Ortho Clinical Diagnostics (2019-2024)
    Table 85. Ortho Clinical Diagnostics Recent Developments
    Table 86. Zhejiang Orient Gene Biotech Basic Information List
    Table 87. Zhejiang Orient Gene Biotech Description and Business Overview
    Table 88. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Zhejiang Orient Gene Biotech (2019-2024)
    Table 90. Zhejiang Orient Gene Biotech Recent Developments
    Table 91. Innovita Biological Technology Basic Information List
    Table 92. Innovita Biological Technology Description and Business Overview
    Table 93. Innovita Biological Technology COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Innovita Biological Technology (2019-2024)
    Table 95. Innovita Biological Technology Recent Developments
    Table 96. Guangzhou Wondfo Biotech Basic Information List
    Table 97. Guangzhou Wondfo Biotech Description and Business Overview
    Table 98. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Guangzhou Wondfo Biotech (2019-2024)
    Table 100. Guangzhou Wondfo Biotech Recent Developments
    Table 101. Guangdong Hecin-Scientific Basic Information List
    Table 102. Guangdong Hecin-Scientific Description and Business Overview
    Table 103. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Guangdong Hecin-Scientific (2019-2024)
    Table 105. Guangdong Hecin-Scientific Recent Developments
    Table 106. Dynamiker Biotechnology (Tianjin) Basic Information List
    Table 107. Dynamiker Biotechnology (Tianjin) Description and Business Overview
    Table 108. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Dynamiker Biotechnology (Tianjin) (2019-2024)
    Table 110. Dynamiker Biotechnology (Tianjin) Recent Developments
    Table 111. ADVAITE Basic Information List
    Table 112. ADVAITE Description and Business Overview
    Table 113. ADVAITE COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 114. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of ADVAITE (2019-2024)
    Table 115. ADVAITE Recent Developments
    Table 116. Mayo Clinic Laboratories Basic Information List
    Table 117. Mayo Clinic Laboratories Description and Business Overview
    Table 118. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 119. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Mayo Clinic Laboratories (2019-2024)
    Table 120. Mayo Clinic Laboratories Recent Developments
    Table 121. Chembio Diagnostics Basic Information List
    Table 122. Chembio Diagnostics Description and Business Overview
    Table 123. Chembio Diagnostics COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 124. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Chembio Diagnostics (2019-2024)
    Table 125. Chembio Diagnostics Recent Developments
    Table 126. Mount Sinai Laboratory Basic Information List
    Table 127. Mount Sinai Laboratory Description and Business Overview
    Table 128. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 129. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Mount Sinai Laboratory (2019-2024)
    Table 130. Mount Sinai Laboratory Recent Developments
    Table 131. QIAGEN Basic Information List
    Table 132. QIAGEN Description and Business Overview
    Table 133. QIAGEN COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 134. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of QIAGEN (2019-2024)
    Table 135. QIAGEN Recent Developments
    Table 136. Bioer Basic Information List
    Table 137. Bioer Description and Business Overview
    Table 138. Bioer COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 139. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Bioer (2019-2024)
    Table 140. Bioer Recent Developments
    Table 141. Biosynex Basic Information List
    Table 142. Biosynex Description and Business Overview
    Table 143. Biosynex COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 144. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Biosynex (2019-2024)
    Table 145. Biosynex Recent Developments
    Table 146. Esco Basic Information List
    Table 147. Esco Description and Business Overview
    Table 148. Esco COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 149. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Esco (2019-2024)
    Table 150. Esco Recent Developments
    Table 151. Analytik Jena Basic Information List
    Table 152. Analytik Jena Description and Business Overview
    Table 153. Analytik Jena COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 154. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Analytik Jena (2019-2024)
    Table 155. Analytik Jena Recent Developments
    Table 156. Techne Basic Information List
    Table 157. Techne Description and Business Overview
    Table 158. Techne COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 159. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Techne (2019-2024)
    Table 160. Techne Recent Developments
    Table 161. Da An Gene Basic Information List
    Table 162. Da An Gene Description and Business Overview
    Table 163. Da An Gene COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 164. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Da An Gene (2019-2024)
    Table 165. Da An Gene Recent Developments
    Table 166. BGI Basic Information List
    Table 167. BGI Description and Business Overview
    Table 168. BGI COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 169. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of BGI (2019-2024)
    Table 170. BGI Recent Developments
    Table 171. Shanghai ZJ Bio-Tech Basic Information List
    Table 172. Shanghai ZJ Bio-Tech Description and Business Overview
    Table 173. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Products, Services and Solutions
    Table 174. Revenue (US$ Million) in COVID-19 Molecular Diagnostics Business of Shanghai ZJ Bio-Tech (2019-2024)
    Table 175. Shanghai ZJ Bio-Tech Recent Developments
    Table 176. Key Raw Materials Lists
    Table 177. Raw Materials Key Suppliers Lists
    Table 178. COVID-19 Molecular Diagnostics Downstream Customers
    Table 179. COVID-19 Molecular Diagnostics Distributors List
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
    Table 183. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. COVID-19 Molecular Diagnostics Product Picture
    Figure 2. Global COVID-19 Molecular Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. COVID-19 Molecular Diagnostics Report Years Considered
    Figure 5. Global COVID-19 Molecular Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 Molecular Diagnostics Revenue in 2023
    Figure 7. COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. High-throughput Sequencing Picture
    Figure 9. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Picture
    Figure 10. Immunological Detection Picture
    Figure 11. Global COVID-19 Molecular Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global COVID-19 Molecular Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Scientific Research
    Figure 15. Product Picture of Biodiagnostics
    Figure 16. Global COVID-19 Molecular Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global COVID-19 Molecular Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa COVID-19 Molecular Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa COVID-19 Molecular Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions COVID-19 Molecular Diagnostics Sales Value (%), (2019-2030)
    Figure 29. United States COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India COVID-19 Molecular Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India COVID-19 Molecular Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India COVID-19 Molecular Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. COVID-19 Molecular Diagnostics Industrial Chain
    Figure 51. COVID-19 Molecular Diagnostics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.

The global market for COVID-19 Molecular Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation